ESC 365 - Validation of a novel direct method to determine reduced adherence to atorvastatin therapy

EAPC Premium Access

Validation of a novel direct method to determine reduced adherence to atorvastatin therapy

Session: Young Investigators Award - Primary Care & Risk Factor Management

Topic: Lipid-Lowering Agents

Speaker: Professor J. Munkhaugen (Drammen, NO)

Event: ESC Preventive Cardiology 2023

Congress Presentation

Add to my library

About the speaker

Professor John Munkhaugen

Drammen Hospital, Drammen (Norway)

0 follower

3 more presentations in this session

Effect of resistance training on HbA1c and other cardiovascular risk factors in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Speaker: Mr M. Michielsen (Leuven, BE)

Left atrium volume is the predominant cardiac dimension related to new-onset atrial fibrillation in the general population

Speaker: Mr Z. Lu (Beijing, CN)

Impact of traffic-related air pollution on the blood pressure response to exercise in individuals with hypertension

Speaker: Mr H. Hung (Vancouver, CA)

Access the full session

Young Investigators Award - Primary Care & Risk Factor Management

Speakers: Professor J. Munkhaugen, Mr M. Michielsen, Mr Z. Lu, Mr H. Hung

About the event

ESC Preventive Cardiology 2023

13 April - 15 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources